Drug Shortage Report for ACT AMLODIPINE
Report ID | 3348 |
Drug Identification Number | 02297477 |
Brand name | ACT AMLODIPINE |
Common or Proper name | AMLODIPINE |
Company Name | TEVA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | AMLODIPINE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-17 |
Estimated end date | 2017-07-31 |
Actual end date | 2017-09-01 |
Shortage status | Resolved |
Updated date | 2017-09-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-09-19 | French | Compare |
v4 | 2017-09-19 | English | Compare |
v3 | 2017-03-18 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v1 | 2017-03-17 | English | Compare |
Showing 1 to 5 of 5